We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
WHX Labs Dubai 2026
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Nanoparticle and Snake Venom Help Discover Disease-Causing Proteins

By Biotechdaily staff writers
Posted on 22 Mar 2007
A complex molecule and snake venom may provide researchers with a more reliable method of diagnosing human diseases and developing new drugs.

Purdue University (Lafayette, IN, USA) scientists bound a complex nanomolecule, called a dendrimer, to a glowing identification tag that was delivered to specific proteins in living venom cells from a rattlesnake. The scientists aim was to find a better way to ascertain the presence, concentration, and function of proteins involved in disease processes. They also hoped that the new method will facilitate better, more efficient diagnosis in living cells and patients.

Most diagnostic methods use minute dead blood or tissue cell samples in a laboratory dish, said Dr. Andy Tao, a Purdue biochemist and senior author of the study. Because molecular interactions and protein functions are disturbed when samples are collected, scientists cannot obtain an accurate picture of biochemical mechanisms related to illnesses such as cancer and heart disease.

Dr. Tao and his research team used dendrimers because they can pass through cell walls efficiently with little disturbance to the cells and then label specific proteins with isotopic tags while cells are still alive. This allows the scientists to determine the activities of proteins that play roles in specific diseases. Proteins carry genetic messages throughout the cell causing biochemical changes that can determine whether a cell behaves normally or abnormally. Proteins also are important in directing immune responses.

The Purdue scientists reported on their new strategy to discover proteins and protein levels, called soluble polymer-based isotopic labeling (SoPIL), in the February 2007 issue of the journal Chemical Communications.

The problem with the current method of using proteomics--protein profiling--is that we use very small sample amounts so sensitive that we can't effectively use existing technologies to study them, Dr. Tao said. In addition, to study a specific protein and its function, we want to preserve its natural environment and see where two molecules meet and what the interaction is when they bind. Taking small samples of blood, cells or tissue to study extracted proteins in laboratory dishes [damage] the sample and the natural environment is destroyed.

The dendrimers would carry one of the stable isotopic or fluorescent labels to identify the presence or absence of a protein that can be further developed for use as a disease indicator, or biomarker. Snake venom cells were used because they have a very high concentration of proteins similar to some found in human blood, Dr. Tao said. The proteins apparently are part of the biochemical process that affects blood clotting or hemorrhage. Understanding how the proteins behave could be useful in diagnosis and drug development and help determine predisposition to heart disease and cancer, and also be useful in diagnosis and drug development.


Related Links:
Purdue University

Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
Alcohol Testing Device
Dräger Alcotest 7000

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
22 Mar 2007  |   BioResearch

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
22 Mar 2007  |   BioResearch

New Method Simplifies Preparation of Tumor Genomic DNA Libraries
22 Mar 2007  |   BioResearch